Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorbald van Hall

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Oncoimmunology|February 6, 2018
T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapyElien M Doorduijn, Marjolein Sluijter, Koen A Marijt, et al.
Frontiers in Oncology|December 12, 2022
<i>In vivo</i> modelling of cutaneous T-cell lymphoma: The role of SOCS1Yixin Luo, Maarten H Vermeer, Frank R de Gruijl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2016
The MHC Class I Cancer-Associated Neoepitope Trh4 Linked with Impaired Peptide Processing Induces a Unique Noncanonical TCR ConformerIda Hafstrand, Elien M Doorduijn, Adil Doganay Duru, et al.
Biochemistry and Biophysics Reports|September 4, 2023
Socs1-knockout in skin-resident CD4<sup>+</sup> T cells in a protracted contact-allergic reaction results in an autonomous skin inflammation with features of early-stage mycosis fungoidesYixin Luo, Maarten H Vermeer, Sanne de Haan, et al.
JCI Insight|December 7, 2018
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapyMarieke F Fransen, Mark Schoonderwoerd, Philipp Knopf, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 3, 2002
Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitopeLukas C Heukamp, Thorbald van Hall, Ferry Ossendorp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1Thorbald van Hall, Sandra Laban, Danijela Koppers-Lalic, et al.
Journal for Immunotherapy of Cancer|June 15, 2019
Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signalingKoen A Marijt, Marjolein Sluijter, Laura Blijleven, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 29, 2010
CD8+ T cell responses against TAP-inhibited cells are readily detected in the human populationMargit H Lampen, Marieke C Verweij, Bianca Querido, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapyJim Middelburg, Gaby Schaap, Marjolein Sluijter, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Oncoimmunology|February 6, 2018
T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapyElien M Doorduijn, Marjolein Sluijter, Koen A Marijt, et al.
Frontiers in Oncology|December 12, 2022
<i>In vivo</i> modelling of cutaneous T-cell lymphoma: The role of SOCS1Yixin Luo, Maarten H Vermeer, Frank R de Gruijl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2016
The MHC Class I Cancer-Associated Neoepitope Trh4 Linked with Impaired Peptide Processing Induces a Unique Noncanonical TCR ConformerIda Hafstrand, Elien M Doorduijn, Adil Doganay Duru, et al.
Biochemistry and Biophysics Reports|September 4, 2023
Socs1-knockout in skin-resident CD4<sup>+</sup> T cells in a protracted contact-allergic reaction results in an autonomous skin inflammation with features of early-stage mycosis fungoidesYixin Luo, Maarten H Vermeer, Sanne de Haan, et al.
JCI Insight|December 7, 2018
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapyMarieke F Fransen, Mark Schoonderwoerd, Philipp Knopf, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 3, 2002
Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitopeLukas C Heukamp, Thorbald van Hall, Ferry Ossendorp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1Thorbald van Hall, Sandra Laban, Danijela Koppers-Lalic, et al.
Journal for Immunotherapy of Cancer|June 15, 2019
Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signalingKoen A Marijt, Marjolein Sluijter, Laura Blijleven, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 29, 2010
CD8+ T cell responses against TAP-inhibited cells are readily detected in the human populationMargit H Lampen, Marieke C Verweij, Bianca Querido, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Cancer vaccines compensate for the insufficient induction of protective tumor-specific immunity of CD3 bispecific antibody therapyJim Middelburg, Gaby Schaap, Marjolein Sluijter, et al.
Pageof 13